Clinical Trial Update: Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing pharmacokinetics of infliximab in pediatric Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Crohn Disease, Child, Only | Phase 4 | Status: RECRUITING